MétaCan
Menu
Back to cohort

Improvement effect of recombinant human erythropoietin on cognition disorders in acute brain infarction patients

2017· article· en· W3031074057 on OpenAlexaboutno aff
Daihua Yu, Wei Li, Qian Yang, Xude Sun, Changjun Gao

Bibliographic record

VenueChin J Crit Care Med(Electronic Edition) · 2017
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disease Mechanisms and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsErythropoietinMedicineCognitionMontreal Cognitive AssessmentInternal medicineInfarctionBrain infarctionCardiologyCognitive impairmentMyocardial infarctionIschemiaPsychiatry

Abstract

fetched live from OpenAlex

Objective To study the improvement effect of recombinant human erythropoietin (rHu-EPO) on cognition disorders in acute brain infarction patients. Methods Acute brain infarction patients with cognition disorders were randomly divided into the control group (16 cases) and rHu-EPO group (18 cases), and two cases in each group were initiatively dropped out during therapy. Patients in the control group received conventional treatment, and patients in the rHu-EPO group were given subcutaneous injection of 30 IU/kg rHu-EPO 3 times per week, and lasted for 4 weeks additionally. Montreal cognitive assessment scales (MOCA) were used to evaluate cognitive function, neural function defect were scaled according to the national institutes of health neurological deficit score (NIHSS) and infarction sizes were determined by magnetic resonance imaging before and after therapy. Results Compared with before therapy, the MOCA score (t = 1.684, P = 0.035; t = 3.622, P = 0.011), language function scores (t = 2.258, P = 0.025; t = 3.472, P = 0.019) and delayed memory function scores (t = 2.665, P = 0.018; t = 4.826, P = 0.026) in the control group and rHu-EPO group all increased markedly, and the MOCA score [(20.21 ± 2.63) vs. (16.99 ± 2.28); t = 4.183, P = 0.011], language function scores [(2.76 ± 0.83) vs. (1.66 ± 0.71); t = 4.865, P = 0.008] and delayed memory function scores [(4.66 ± 1.38) vs. (3.12 ± 1.02); t = 2.643, P = 0.025] in the rHu-EPO group were much higher than those in the control group. After therapy, the NIHSS in the control group and rHu-EPO group were also lower than those before therapy (t = 3.506, 8.126, P = 0.018, 0.002), and in the rHu-EPO group reduced obviously as compared with that in the control group (t = 2.508, P = 0.026). Meanwhile, the infarction sizes after therapy only in the rHu-EPO group decreased as compared with before therapy [(12.8 ± 3.5) cm3 vs. (8.2 ± 2.3) cm3; t = 6.204, P = 0.001], and in the rHu-EPO group were much smaller than those in the control group (t = 3.268, P = 0.022). Conclusion Based on conventional therapy, rHu-EPO may effectively improve cognition disorders in acute brain infarction patients, especially language and delayed memory function. Key words: Brain infarction; Cognition disorders; Recombinant human erythropoietin

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.002

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.278
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueChin J Crit Care Med(Electronic Edition)Same topicNeurological Disease Mechanisms and TreatmentsFrench-language works237,207